✦ LIBER ✦

940 SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE HCV POLYMERASE INHIBITOR VCH-222 FOLLOWING SINGLE DOSE ADMINISTRATION IN HEALTHY VOLUNTEERS AND ANTIVIRAL ACTIVITY IN HCV-INFECTED INDIVIDUALS

✍ Scribed by C. Cooper; R. Larouche; B. Bourgault; N. Chauret; L. Proulx

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

854 RESULTS OF A SAFETY, TOLERABILITY AN

✍ L. Proulx; B. Bourgault; N. Chauret; R. Larouche; M. Tanguay; R. Thibert 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

747 PHARMACOKINETICS OF THE HCV POLYMERA

✍ E. Dumas; W. Awni; D. Cohen; B. Bernstein; A. Nada; Y.L. Chiu; C. Klein 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 52 KB

956 PHARMACOKINETICS, TOLERABILITY AND E

✍ R. Menon; D. Cohen; A. Nada; E. Olson Dumas; Y.-L. Chiu; T. Podsadecki; W. Awni; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

622 SAFETY, AND TOLERABILITY OF NIM811,

✍ J. Ke; E. Lawitz; R. Rozier; T. Marbury; N. Nguyen; D. Serra; K. Dole; J. Praest 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

1204 PHARMACOKINETICS, SAFETY AND TOLERA

✍ Dumas, E.O.; Lawal, A.; Menon, R.M.; Podsadecki, T.; Awni, W.; Dutta, S.; Willia 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB

92 SAFETY, TOLERABILITY AND ANTIVIRAL AC

✍ E. Lawitz; C. Cooper; M. Rodriguez-Torres; R. Ghalib; R. Lalonde; A. Sheikh; B. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB